Lisocabtagene maraleucel in patients with relapsed or refractory marginal zone lymphoma (TRANSCEND FL): primary analysis results from the global, multicohort, single-arm, phase 2 study
Memorial Sloan Kettering Cancer Center · UPMC Hillman Cancer Center · +33 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
4
total citations
- FWCI
- 80.71
- Percentile
- 100%
- References
- 34
Too recent for citation history.
Authors
30- MLM Lia PalombaCorresponding
Memorial Sloan Kettering Cancer Center
- SJStephen J Schuster
UPMC Hillman Cancer Center, University of Pennsylvania
- RKReem Karmali
Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- APAlan P Skarbnik
Novant Health
- JAJeremy Abramson
Massachusetts General Hospital, Center for Cancer Research
Topics & keywords
Topics
Keywords
- Refractory (planetary science)
- Phases of clinical research
- Phase (matter)
- Lymphoma
- Primary (astronomy)
No related works found for this paper.